About The Study: This cross-sectional study of privately insured patients found a more than 2-fold increase in use of ...

Study of those who started taking blockbuster weight loss drugs in 2021 suggests patients need support services, not just the ...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 ...

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic ...

In a world increasingly focused on health and wellness, finding effective solutions for weight management can be challenging.

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

You may qualify for a study at the University of Alabama at Birmingham exploring the effects of sacubitril/valsartan on your ...

Reviewed by Dietitian Emily Lachtrupp, M.S., RD Ever since berberine made headlines last year for being touted as “nature’s ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

Centene's Medicaid revenue fell slightly in the third quarter as costs outpaced the payment increases states implemented.

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates ...